Krebs Biochemicals & Industries Ltd.

NSE: KREBSBIO | BSE: 524518 | ISIN: INE268B01013 | Industry: Pharmaceuticals
|
72.9300 -1.47 (-1.98%)
NSE May 22, 2025 15:31 PM
Volume: 8,592
 

72.93
-1.98%
Board Meeting Intimation for Rights Issue Of Equity Shares
BSE India
KREBS BIOCHEMICALS has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2018 ,inter alias, to consider and approve Pursuant to Regulation 30 of SEBI (LODR) Regulations, we wish to inform you that in addition to the items of business to be considered and approved as mentioned in the notice of board meeting dated 23rd July 2018, the Board also to consider the following:...
More from Krebs Biochemicals & Industries Ltd.
Recommended